Neurogene (NGNE) Tax Rate (2013 - 2014)
Neurogene's (NGNE) quarterly Tax Rate came in at 2.29% in Q4 2014, down 229.0% YoY from 1.77% in Q4 2013, and down 64907.8% on a QoQ basis from 0.0% in Q3 2014.
Powered by 
Analysis
Neurogene (NGNE) Tax Rate (2013 - 2014) Analysis & Trends
Neurogene (NGNE) has 2 years of Tax Rate data on file, last reported at 2.29% in Q4 2014.
- Quarterly Tax Rate fell 229.0% year-over-year to 2.29% in Q4 2014, while the trailing twelve-month figure through Dec 2014 was 0.75% (changed N/A YoY) and the FY2015 annual result came in at 2.04%, down 127.0% from the prior year.
- Tax Rate retreated to 2.29% in Q4 2014, from 0.0% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.15% in Q3 2013 to a low of 2.29% in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | -2.29% |
| Sep 30, 2014 | 0.00% |
| Dec 31, 2013 | 10.14% |
| Sep 30, 2013 | 0.15% |